Clinical Trials Directory

Trials / Completed

CompletedNCT01450007

Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery

Perineural Versus Systemic Dexamethasone as an Analgesic Adjunct to Ultrasound-Guided Ropivacaine Interscalene Blockade in Arthroscopic Rotator Cuff Repair

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pre-operative perineural injection of dexamethasone mixed with local anesthetic in peripheral nerve blockade for orthopedic surgery has been shown to prolong the length of analgesia, improve visual analog pain scores, decrease post-operative opioid use, and decrease post-operative nausea. No study has been published to determine if this effect is a result of systemic absorption of dexamethasone or is a local effect of the drug on neuronal activity at the injection site. This study is a prospective, randomized, double-blind, controlled study to compare pain block with (1) ropivacaine and saline plus intravenous saline vs (2) ropivacaine and dexamethasone plus intravenous saline vs (3) ropivacaine and saline plus intravenous dexamethasone. Patients will be recruited sequentially and assigned to the three groups at random in equal ratios. The hypothesis is that dexamethasone injected perineurally in combination with ropivacaine for interscalene brachial plexus block will yield longer duration of sensory blockade as compared to ropivacaine alone without intravenous or perineural dexamethasone and as compared to ropivacaine and intravenous dexamethasone. This result will suggest that the effect of dexamethasone is a result of direct neuronal activity at the injection site versus systemic absorption.

Conditions

Interventions

TypeNameDescription
DRUGRopivacaine25 ml ropivacaine 0.5%
DRUGDexamethasone8 mg dexamethasone (perineural)
DRUGDexamethasone8 mg dexamethasone (0.8 ml dexamethasone, 4.2 ml saline) to total volume of 5 ml (intravenous)
DRUGNormal saline5 ml normal saline (intravenous)
DRUGNormal saline0.8 ml normal saline (perineural)

Timeline

Start date
2012-05-01
Primary completion
2015-05-01
Completion
2015-07-01
First posted
2011-10-10
Last updated
2016-06-17
Results posted
2016-05-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01450007. Inclusion in this directory is not an endorsement.